rs148414498

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_201596.3(CACNB2):​c.1293G>A​(p.Gln431Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,532,870 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00088 ( 2 hom., cov: 30)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

CACNB2
NM_201596.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.35

Publications

2 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Laboratory for Molecular Medicine
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 10-18536187-G-A is Benign according to our data. Variant chr10-18536187-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 416839.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.35 with no splicing effect.
BS2
High AC in GnomAd4 at 128 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNB2NM_201596.3 linkc.1293G>A p.Gln431Gln synonymous_variant Exon 12 of 14 ENST00000324631.13 NP_963890.2 Q08289-1
CACNB2NM_201590.3 linkc.1131G>A p.Gln377Gln synonymous_variant Exon 11 of 13 ENST00000377329.10 NP_963884.2 Q08289-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNB2ENST00000324631.13 linkc.1293G>A p.Gln431Gln synonymous_variant Exon 12 of 14 1 NM_201596.3 ENSP00000320025.8 Q08289-1
CACNB2ENST00000377329.10 linkc.1131G>A p.Gln377Gln synonymous_variant Exon 11 of 13 1 NM_201590.3 ENSP00000366546.4 Q08289-3

Frequencies

GnomAD3 genomes
AF:
0.000887
AC:
129
AN:
145416
Hom.:
2
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00307
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000139
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00180
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000330
AC:
83
AN:
251386
AF XY:
0.000272
show subpopulations
Gnomad AFR exome
AF:
0.00295
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000154
AC:
213
AN:
1387366
Hom.:
0
Cov.:
26
AF XY:
0.000160
AC XY:
111
AN XY:
692058
show subpopulations
African (AFR)
AF:
0.00430
AC:
133
AN:
30944
American (AMR)
AF:
0.0000926
AC:
4
AN:
43190
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24544
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35288
South Asian (SAS)
AF:
0.000682
AC:
58
AN:
85094
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50492
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5494
European-Non Finnish (NFE)
AF:
0.00000568
AC:
6
AN:
1056028
Other (OTH)
AF:
0.000213
AC:
12
AN:
56292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000880
AC:
128
AN:
145504
Hom.:
2
Cov.:
30
AF XY:
0.000879
AC XY:
62
AN XY:
70548
show subpopulations
African (AFR)
AF:
0.00306
AC:
119
AN:
38912
American (AMR)
AF:
0.0000695
AC:
1
AN:
14388
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3434
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4728
South Asian (SAS)
AF:
0.00180
AC:
8
AN:
4442
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9294
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
276
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67094
Other (OTH)
AF:
0.00
AC:
0
AN:
2032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000343
Hom.:
0
Bravo
AF:
0.000914
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 23, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNB2: BP4, BP7 -

Brugada syndrome 4 Benign:1
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CACNB2-related disorder Benign:1
Apr 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Cardiovascular phenotype Benign:1
Jun 20, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
6.7
DANN
Benign
0.86
PhyloP100
2.3
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148414498; hg19: chr10-18825116; COSMIC: COSV99994427; COSMIC: COSV99994427; API